Other peptides under investigation Several additional peptides are being studied for disc-related applications, though with less established evidence: Vasoactive Intestinal Peptide (VIP) has demonstrated the ability to slow disc degeneration progression and improve aggrecan levels in mouse studies
Some patients may experience transient changes in blood pressure, though long-term cardiovascular outcomes studies have generally shown beneficial or neutral effects of GLP-1 receptor agonists on cardiovascular events
Testing can provide useful information, but prescription decisions, dose changes, severe symptoms, and abnormal results should be discussed with a qualified healthcare provider
Our work involves synthesizing peptides to the highest possible standards of purity for one reason: to provide researchers with reliable tools
It is not an FDA-approved drug and not a legal over-the-counter supplement
I found a few articles about expired medicines